fda warning letters compounding semaglutide october 2025 Last month, the issued 25 to telehealth companies over what it called false or misleading claims about compounded GLP-1 medications FDA orders pharmacies to cease

Analysts estimate that weight loss medications could become a $150+ billion global market by 2031

Validation of leaf ozone symptoms in natural vegetation using microscopical methods

Most adults with a BMI over 27 and weight-related health conditions, or a BMI over 30, may qualify for GLP therapy

10.1016/j.clindermatol.2007.08.015 Clin

Out of all the antioxidant ingredients out there, glutathione is often touted as one of the best and most powerful

This solution is anchored by the nations largest source of closed medical and pharmacy claims (covering over 300 million patients across hundreds of payers with 9+ years of history), and it adds context those claims with lab data from the two largest outpatient labs that capture over 60% of U.S